Майметси

Майметси combines Metformin Hydrochloride and Sitagliptin for blood sugar control in adults with type 2 diabetes. This oral medication supports glucose regulation and is prescribed alongside diet and exercise. Suitable for patients seeking combined therapy options.

Майметси is used to improve blood sugar levels in adults with type 2 diabetes when diet and exercise alone are insufficient. It combines two active ingredients to help manage glucose production and utilization. This medication is often prescribed for patients already taking Metformin or Sitagliptin separately.

Users may experience improved energy levels and reduced symptoms of high blood sugar such as frequent urination or excessive thirst. Some individuals report better overall well-being when blood sugar levels are stabilized. Effects vary and may take time to become noticeable.

Store Майметси at room temperature away from moisture and heat. Keep out of reach of children and pets. Do not use if the packaging is damaged or the tablets show signs of tampering. Consult a healthcare provider before starting or stopping this medication.

Alcohol may increase the risk of lactic acidosis or low blood sugar when combined with this medication. Certain medications, such as diuretics or corticosteroids, may affect blood sugar levels. Always inform your doctor about all prescription, over-the-counter, and herbal products you are using.